HESTER BIOSCIENCES
Sector : Pharmaceuticals and health care | Smallcap | BSE
Here's the live share price of Hester Biosciences along with daily highs, lows, percentage changes and volume trends, and, all financial information.
-1.72₹ -26.00
As on Jan 14, 2026, 4:01 PM IST
Hester Biosciences Price Performance
Today's LowToday's High
₹1,482.05₹1,528.70
₹1,482.05
52 Weeks' Low52 Weeks' High
₹1,246.75₹2,347.70
₹1,482.05
Open Price
₹1,508.10
Prev. Close
₹1,508.05
Volume
162
Over the last 5 years, the share price of Hester Biosciences has declined 2.86% CAGR. Over the past year, the corresponding return has been -33.65%.
Hester Biosciences’s current P/E of 28.76x helps give context to how the market is valuing the stock based on recent earnings and growth expectations.
Hester Biosciences Peer Comparision
Name | 1W(%) | 1M(%) | 3M(%) | 6M(%) | 1Y(%) | 3Y(%) | 5Y(%) |
|---|---|---|---|---|---|---|---|
| Hester Biosciences | -8.83 | -6.94 | -13.18 | -19.99 | -33.65 | -5.50 | -2.86 |
| Sun Pharmaceutical Industries | -4.60 | -5.38 | 2.81 | 1.10 | -3.86 | 17.98 | 22.88 |
| Divi's Laboratories | -4.39 | 0.06 | -3.18 | -6.38 | 5.88 | 23.97 | 11.26 |
| Torrent Pharmaceuticals | -2.15 | 5.88 | 13.75 | 17.50 | 23.01 | 36.63 | 23.48 |
| Cipla | -2.23 | -4.82 | -7.63 | -3.37 | -0.93 | 10.61 | 11.29 |
| Lupin | -0.84 | 5.02 | 13.28 | 14.04 | 1.84 | 42.61 | 14.70 |
| Dr. Reddy's Laboratories | -4.08 | -6.91 | -3.66 | -4.72 | -10.87 | 11.27 | 2.34 |
| Mankind Pharma | -3.01 | 4.62 | -7.96 | -16.96 | -16.08 | 16.33 | 9.50 |
| Zydus Lifesciences | -4.61 | -3.99 | -9.67 | -8.67 | -11.62 | 26.30 | 11.94 |
| Alkem Laboratories | 0.49 | 3.60 | 5.89 | 20.20 | 10.36 | 24.18 | 13.32 |
| Aurobindo Pharma | -4.19 | -0.17 | 5.35 | 3.93 | 0.73 | 38.42 | 4.29 |
| Abbott India | -2.05 | 0.05 | -7.29 | -18.84 | -1.22 | 8.19 | 13.21 |
| Laurus Labs | -3.34 | 8.63 | 24.47 | 32.37 | 91.99 | 45.49 | 24.34 |
| Biocon | -2.12 | -2.96 | 7.75 | -0.05 | -2.24 | 14.80 | -4.08 |
| Glenmark Pharmaceuticals | -4.88 | 1.24 | 6.14 | -9.39 | 32.68 | 68.53 | 31.03 |
| GlaxoSmithKline Pharmaceuticals | -2.89 | -7.31 | -13.62 | -25.11 | 14.90 | 22.37 | 9.48 |
| Ipca Laboratories | 0.20 | 5.23 | 16.29 | 4.09 | -4.50 | 20.47 | 7.15 |
| Anthem Biosciences | -5.04 | -10.91 | -19.39 | -14.75 | -14.75 | -5.18 | -3.14 |
| Ajanta Pharma | -5.19 | 2.50 | 13.06 | 2.12 | -3.90 | 32.03 | 18.10 |
| Emcure Pharmaceuticals | 3.04 | 12.71 | 17.50 | 16.15 | 16.47 | 5.02 | 2.98 |
Over the last one year, Hester Biosciences has declined 33.65% compared to peers like Sun Pharmaceutical Industries (-3.86%), Divi's Laboratories (5.88%), Torrent Pharmaceuticals (23.01%). From a 5 year perspective, Hester Biosciences has underperformed peers relative to Sun Pharmaceutical Industries (22.88%) and Divi's Laboratories (11.26%).
Hester Biosciences Financials
Hester Biosciences Stock Technicals
Moving Average
| Day | SMA | EMA |
|---|---|---|
| 5 | 1,580.07 | 1,549.51 |
| 10 | 1,583.58 | 1,566.03 |
| 20 | 1,583.82 | 1,581.08 |
| 50 | 1,617.62 | 1,628.51 |
| 100 | 1,763.79 | 1,700.12 |
| 200 | 1,783.95 | 1,786.36 |
Hester Biosciences Share Holding Pattern
In the latest quarter, Hester Biosciences remained same as its previous close in promoter holding, while DII stake increased to 0.01%, FII holding fell to 0.52%, and public shareholding moved up to 45.75% compared to the previous quarter — reflecting a shift in investor sentiment across categories.
Hester Biosciences Corporate Actions
Date Time | Announcement |
|---|---|
| Jan 08, 2026, 5:36 AM IST | Hester Biosciences - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 |
| Nov 20, 2025, 3:22 PM IST | Hester Biosciences L - Intimation Under Regulation 30(5) Of The SEBI (LODR) Regulations, 2015 |
| Nov 20, 2025, 3:12 PM IST | Hester Biosciences L - Announcement under Regulation 30 (LODR)-Change in Management |
| Nov 20, 2025, 3:10 PM IST | Hester Biosciences L - Outcome Of Resolutions Passed By The Board Of Directors By Circulation |
| Nov 14, 2025, 10:31 PM IST | Hester Biosciences L - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome |
About Hester Biosciences
Hester Biosciences Ltd. is a Public Limited Listed company incorporated on 29/04/1987 and has its registered office in the State of Gujarat, India. Company's Corporate Identification Number(CIN) is L99999GJ1987PLC022333 and registration number is 022333. Currently Company is involved in the business activities of Manufacture of pharmaceuticals, medicinal chemical and botanical products. Company's Total Operating Revenue is Rs. 286.47 Cr. and Equity Capital is Rs. 8.51 Cr. for the Year ended 31/03/2025.
- IndustryPharmaceuticals
- Address�Pushpak� 1st Floor, Panchvati Circle, Ahmedabad Gujarat 380006
- Contact
Management
- Dr. Bhupendra GandhiChairman
- Mr. Rajiv GandhiManaging Director & CEO
- Ms. Priya GandhiExecutive Director
- Mr. Ravin GandhiDirector
- Mr. Sanjiv GandhiDirector
- Mr. Ashok BhadakalIndependent Director
- Ms. Sandhya PatelIndependent Director
- Mr. Ameet DesaiIndependent Director
- Mr. Anil JainIndependent Director
- Mr. Jatin TrivediIndependent Director
- Ms. Nina GandhiAlternate Director
FAQs on Hester Biosciences Share Price
What is the share price of Hester Biosciences?
The share price of any company is dynamic and keeps changing depending on the trade initiated. The shares have a fixed opening rate and closing rate. The share price for Hester Biosciences is ₹1,482.05 as on Jan 14, 2026.
What kind of stock is Hester Biosciences?
The Hester Biosciences is operating in the Pharmaceuticals and health care Sector. It is classified as a Smallcap stock on the BSE.
What is the Market Cap of Hester Biosciences?
The market cap of Hester Biosciences is ₹1,260.76 Cr as on Jan 14, 2026.
What are today's High and Low prices of Hester Biosciences?
Today’s highest and lowest price of Hester Biosciences are ₹1,528.70 and ₹1,482.05.
What are the 52 Week High and 52 Week Low of Hester Biosciences?
The 52-week high/low is the highest and lowest price at which Hester Biosciences stock has traded in the past 52-week or nearly a year. The 52-week high of Hester Biosciences is ₹2,347.70 and 52-week low of Hester Biosciences is ₹1,246.75 as on Jan 14, 2026.
How has the Hester Biosciences performed historically in terms of returns?
The Hester Biosciences has shown returns of -1.72% over the past day, -6.94% for the past month, -13.18% over 3 months, -33.65% over 1 year, -5.5% across 3 years, and -2.86% over 5 years.
What are the P/E ratio, dividend yield and PB ratio of Hester Biosciences?
P/E ratio of and PB ratio of Hester Biosciences are 28.76 and 3.73 on Jan 14, 2026. While the company gives a dividend yield of 0.47 per annum.
✕
Market Pulse